Johnson & Johnson Drug Recalls. Johnson & Johnson’s CEO Bill Weldon is schedule to testify before Congress today about his company’s handling of recalls of Children’s Tylenol and other drugs. According to The New York Times, Weldon’s prepared testimony for his appearance before the House Committee on Oversight and Government … [Read more...]
J&J CEO to Concede Mistakes in Drug Recalls
J&J CEO Set to Answer Drug Recall
Johnson & Johnson CEO. Johnson & Johnson CEO Bill Weldon is expected to appear at a congressional hearing tomorrow to testify about a string of drug recalls that have tarnished his company’s once stellar reputation. It will be Weldon’s first major appearance on the recalls. Other witnesses due to appear before the U.S. House … [Read more...]
CEO Leaves Actavis Group
CEO Leaves Actavis Group. Just days after its U.S. division recalled all of its generic drugs, Icelandic drug maker Actavis Group announced that its CEO is stepping down. However, in announcing the departure of Róbert Wessman, the company made no mention of Actavis Totowa's recent safety problems, which also included an April recall … [Read more...]
Heparin Hearing to Feature Baxter CEO
Congressional Hearing Feature Baxter CEO. A congressional hearing into tainted heparin that begins tomorrow will feature testimony from the Chief Executive Officer of Baxter International. Baxter International supplied about 50 percent of the heparin used in the US, and recalled most of its heparin products in February following … [Read more...]
Baxter CEO Concedes Company About Supplier of Tainted Heparin
Baxter CEO Tainted Heparin. Baxter International Inc.’s CEO, Robert Parkinson, said Baxter does not monitor its supply chain deeply enough to know much about the Chinese supplier that made an active ingredient in Baxter Heparin. Parkinson also claims Baxter was unaware the Chinese supplier was never inspected by the Food & … [Read more...]
Bausch & Lomb CEO Steps Down, 2 Years after Renu with MoistureLoc Recall
Bausch & Lomb CEO Steps Down. The Bausch & Lomb CEO who oversaw the Renu with MoistureLoc recall debacle has stepped down. Last year, under Ronald Zarella, who served as Bausch & Lomb CEO since 2001, the company was sold to private equity firm Warburg Pincus of New York City. The sale ended Bausch & Lomb's almost 70-year run … [Read more...]
Stronger Warning Label for MS Drug
Biogen Idec to Seek MS Drug Stronger Warning. The head of Biogen Idec Inc. said in an interview Wednesday his company will recommend to regulators within a month that the warning label be strengthened on a multiple sclerosis drug the company hopes to return to the market despite safety concerns. James Mullen said Biogen Idec will … [Read more...]
